| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Hoch PH, Pennes HH, Catte... |
Psychoses produced by administration of drugs |
Res. Publ. Ass. Nerv... |
1953 |
| Sacchi U, Brusa A, Sorian... |
Alterazioni istologiche del sistema nervosa centrale provocate sperime... |
Sistema nerv. |
1957 |
| Abramson HA, Hewitt MP, L... |
The stablemate concept of therapy as affected by LSD in schizophrenia |
J. Psychol. |
1958 |
| Giberti F, Gregoretti L |
Studio comparativo degli effetti psicopatologici della monoetilamide d... |
Sistema nerv. |
1958 |
| Herold M, Cahn J, Dubrasq... |
Contribution á un concept biochimique des psychoses experiméntales. V... |
Compt. rend. Soc. bi... |
1958 |
| Delay J, Benda P |
L'expérience lysergique. LSD-25. A propos de 75 observations cliniqu... |
Encéphale, Paris |
1958 |
| Martin AJ |
Schizophreniform reactions under day hospital LSD therapy |
IInd International C... |
1959 |
| Rosenbaum G, Cohen BD, Lu... |
Comparison of Sernyl with other drugs. Simulation of schizophrenic pe... |
A.M.A. Arch. Gen. Ps... |
1959 |
| Sandoz Laboratories Basle |
Methysergide (UML-491), a new serotonin antagonist |
Scientific Exhibit, ... |
1960 |
| Jovanovic D, Kandic B, Kr... |
O nekim aspektima primene LSD-25 u nasoj Klinickoj psihijatrijsdkoj pr... |
Vojnosanit. Pregl. |
1960 |
| B C |
La psilocybin. |
Sem. med. prof. med.... |
1960 |
| Brown BB |
CNS stimulants and electrical brain activity in spontaneously behaving... |
Fed. Proc. |
1961 |
| Hollister LE |
Clinical, biochemical and psychologic effects of Psilocybin |
Arch. internat. Phar... |
1961 |
| DELAHUNT CS, O'CONNOR RA,... |
Toxic retinopathy following prolonged treatment with dl-p-trifluoromet... |
Toxicol Appl Pharmac... |
1963 |
| Hirschhorn K, Cohen MM |
Nonpsychic effects of lysergic acid diethylamide |
Ann. intern. med |
1967 |
| Vojtéchovský M, Krus D, K... |
The influence of tryptophane and 5-HTP pretreatment on experimental ps... |
Active.nerv.sup (Pra... |
1967 |
| Henkin R, Buchsbaum M, We... |
Physiological and psychological effects of LSD in chronic users |
Clin. Res. |
1967 |
| Zsigmond EK |
Letters to the editor of clinical workshop. Anesthetic Considerations ... |
Anesthesiology |
1968 |
| Heninger GR, Bowers MB |
Adverse effects of niacin in emergent psychosis |
Journal American Med... |
1968 |
| Blacker KH, Jones RT, Sto... |
Chronic users of LSD: the 'acidheads' |
Amer. J. Psychiat. |
1968 |
| Welpton DF |
Psychodynamics of chronic lysergic acid diethylamide use. A clinical s... |
J. nerv. ment. Dis. |
1968 |
| Smith DE |
The Psychotomimetic Amphetamines with Special Reference to DOM (STP) T... |
Journal of Psychedel... |
1969 |
| Barren SP, Lowinger PEE |
A clinical examination of chronic LSD uæ in the community. |
Comprahens.Psychiat. |
1970 |
| Holden JMC, Itil T |
The influence of the standard pre-frontal lobotomy operation on halluc... |
Origin and mechanism... |
1970 |
| McGlothlin W, Jamison K, ... |
Marijuana and the use of other drugs |
Nature |
1970 |
| Glass GS, Bowers MB |
Chronic psychosis associated with long-term psychotomimetic drug abuse |
Arch. Gen. Psychiat. |
1970 |
| Cheek FE, Holstein CM |
Lysergic acid diethylamide tartrate (LSD-75) dosage levels, group diff... |
J.nerv.ment.Dis. |
1971 |
| Pahnke WN, Kurland AA, Un... |
The experimental use of psychedelic (LSD) psychotherapy |
Int J Clin Pharmacol |
1971 |
| Savage C, McCabe OL |
(LSD) therapy of drug addiction. |
The drug abuse contr... |
1972 |
| Tucker GL, Quinlan D, Har... |
Chronic hallucinogenic drug abuse and thought disturbance |
Arch. gen. Psychiat. |
1972 |
| Kurland AA, Grof S, Pahnk... |
Psychedelic Drug Assisted Psychotherapy. In Patients With Terminal Can... |
Psychotheramacologic... |
1973 |
| Remschmidt H |
Psychotische Zustandebilder bei jugendlichen Drogenkonsumenten |
Münch. med. Wschr. |
1973 |
| Ketz E |
The effect of anticonvulsants and some psychotropic drugs on the conve... |
Electroericeph.clin.... |
1974 |
| Fossati C |
I Danni Provocati Dall'abuso di Bevande Alcooliche: Possibilita di Dis... |
Clin Ter |
1974 |
| Killam KF |
Drugs on EEG correlates of behavior |
Psychopharmacology B... |
1974 |
| Editorial |
FDA Lists Approved LSD Research Projects |
FDA Consumer |
1975 |
| Biswas B, Ghos JJ |
Delta 9 Tetrahydrocannabinol And Lysergic Acid Diethylamide: Comparati... |
Anat. Anz. |
1975 |
| Nishi K |
The Action Of 5-hydroxytryptamine On Chemoreceptor Discharges Of The C... |
Brit. J. Pharmac. |
1975 |
| Suwanlert S |
A study of kratom eaters in Thailand |
Bulletin on Narcotic... |
1975 |
| Martin WR, Thompson JA, N... |
Physiologic Evidence for Descending Tryptaminergic Pathways in the Spi... |
Life Sci. |
1976 |
| Martin WR, Sloan JW, Vaup... |
Tryptamine in the Brain and Spinal Cord: Its Role in the LSD Response |
Psychopharmacol.Bull... |
1976 |
| Nozaki M, Bell JA |
Responses of flexor reflex to LSD, tryptamine (T), 5-HTP, methoxamine ... |
Fed. Proc. |
1976 |
| Vaupel DB, Nozaki M, Mart... |
Evaluation of Cross Tolerance to beta-Phenethylamine (PEA) and d-amphe... |
Pharmacologist |
1976 |
| Martin WR, Vaupel DB, Slo... |
The Mode Of Action Of LSD-like Hallucinogens And Their Identification |
Psychopharmacology o... |
1976 |
| Cohen MM, Shiloh Y |
Genetic Toxicology Of Lysergic Acid Diethylamide (LSD-25) |
Mutation Research |
1977 |
| Nozaki M, Bell JA, Vaupel... |
Responses of the Flexor Reflex to LSD, Tryptamine, 5-Hydroxytryptophan... |
Psychopharmacology |
1977 |
| Nozaki M, Vaupel DB, Mart... |
A Pharmacologic Comparison of 3,4-Methylenedioxyamphetamine and LSD in... |
Europ.J.Pharmacol. |
1977 |
| Pickworth WB, Sharpe LG, ... |
Transcallosally Evoked Potentials And the EEG In The Decerebrate Dog: ... |
Electroencephalogram... |
1977 |
| Rhead JC, Soskin RA, Ture... |
Psychedelic Drug (DPT)-Assisted Psychotherapy with Alcoholics: A Contr... |
J of Psychedelic Dru... |
1977 |
| Schlemmer RF, Tyler CB, N... |
The Comparitive Effects Of LSD, Mescaline, And DMT On Primate Social A... |
Federation Proceedin... |
1978 |
| Trulson NE, Jacobs BL |
Behavioral Evidence for Denervation Supersensitivity After Destruction... |
Ann.N.Y.Acad.Sci. |
1978 |
| Vaupel DB, Nozaki M, Mart... |
Single dose and cross tolerance studies of beta-phenethylamine, d-amph... |
Europ. J. Pharmacol. |
1978 |
| Vaupel DB, Martin WR |
LSD-like Hallucinogens In The Dog: Validation Studies With Mescaline (... |
Fed. Proc. |
1978 |
| Rappolt RT, Gay G, Inaba ... |
Use of Inderal (Propranolol-Ayerst) in 1-a (Early Stimulative) and 1-b... |
Clin.Toxicol. |
1978 |
| Prozialeck WC, Vogel WH |
MAO Inhibition and the Effects of Centrally Administered LSD Serotonin... |
Psychopharmacology |
1979 |
| Dolphin A, Adrien J, Hamo... |
Identity of (3H)-Dibydroalprenolol Binding Sites and p-Adrenergic Rece... |
Molec.Pharmacol. |
1979 |
| Jasinski DR |
Interdisciplinary Studies on Phencyclidine at the Addiction Research C... |
Psychopharmacol.Bull... |
1980 |
| Nielsen EB, Lee TH, Ellis... |
Following Several Days of Continuous Administration d-Amphetamine Acqu... |
Psychopharmacology |
1980 |
| Hunt CA, Jones RT |
Tolerance and disposition of tetrahydrocannabinol in man |
J Pharmacol Exp Ther |
1980 |
| Fuller RW, Kaiser C |
Effect of 2-(p-chlorophenyl)cyclopropylamine on 5-hydroxyindole concen... |
Biochem Pharmacol |
1980 |
| Weil AT |
The therapeutic value of coca in contemporary medicine |
J Ethnopharmacol |
1981 |
| Abraham HD |
A chronic impairment of colour vision in users of LSD |
Br J Psychiatry |
1982 |
| Snyder SH, Peroutka SJ |
A Possible Role of Serotonin Receptors in Antidepressant Drug Action |
Pharmacopsychiat. |
1982 |
| Leysen JE, Gommeren W |
Characterization and quantification of serotonin-S2 receptor sites on ... |
Archives Internation... |
1984 |
| Weaver KEC |
Letters to the Editor: LSD and Schizophrenia |
Arch. Gen. Psychiatr... |
1984 |
| Strassman RJ |
Adverse reactions to psychedelic drugs. A review of the literature |
J Nerv Ment Dis |
1984 |
| Schmidt CJ, Sonsalla PK, ... |
Methamphetamine-induced depression of monoamine synthesis in the rat: ... |
J Neurochem |
1985 |
| Spencer PS, Schaumburg HH |
Organic solvent neurotoxicityFacts and research needs |
Scand J Work Environ... |
1985 |
| Fundaro' A, Molinengo L, ... |
Action of a chronic administration of mescaline in dynamic behavioural... |
Prog Neuropsychophar... |
1986 |
| Tashkin DP, Coulson AH, C... |
Respiratory symptoms and lung function in habitual heavy smokers of ma... |
Am Rev Respir Dis |
1987 |
| Elferink JG |
Some little-known hallucinogenic plants of the Aztecs |
J Psychoactive Drugs |
1988 |
| Greenblatt DJ |
Urine Drug Testing: What Does it Test? |
New England Law Revi... |
1989 |
| Beebe DK, Walley E |
Update on street drugs in Mississippi |
J Miss State Med Ass... |
1989 |
| Slikker W Jr, Holson RR, ... |
Behavioral and neurochemical effects of orally administered MDMA in th... |
Neurotoxicology |
1989 |
| Gibb JW, Stone DM, Johnso... |
Role of dopamine in the neurotoxicity induced by amphetamines and rela... |
NIDA Res Monogr |
1989 |
| Kosten TR |
Neurobiology of abused drugs. Opioids and stimulants |
J Nerv Ment Dis |
1990 |
| Greer GR,Tolbert R |
The Therapeutic Use of MDMA |
Ecstasy: The clinica... |
1990 |
| Koblin DD |
Nitrous oxide: a cause of cancer or chemotherapeutic adjuvant? |
Semin Surg Oncol |
1990 |
| Darmani NA, Martin BR, Gl... |
Withdrawal from chronic treatment with ±-DOI causes super-sensitivity ... |
Eur J Pharmacol |
1990 |
| Benazzi F, Mazzoli M |
Psychiatric illness associated with 'ecstasy' |
Lancet |
1991 |
| Dornan WA, Katz JL, Ricau... |
The effects of repeated administration of MDMA on the expression of se... |
Pharmacol Biochem Be... |
1991 |
| McGuire P, Fahy T |
Chronic paranoid psychosis after misuse of MDMA ('ecstasy') |
BMJ |
1991 |
| Schifano F |
Chronic atypical psychosis associated with MDMA ('ecstasy') abuse |
Lancet |
1991 |
| Winstock AR |
Chronic paranoid psychosis after misuse of MDMA |
BMJ |
1991 |
| Krystal JH, Price LH, Ops... |
Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood ... |
Am J Drug Alcohol Ab... |
1992 |
| Rezvani AH, Garges PL, Mi... |
Attenuation of alcohol consumption by MDMA (ecstasy) in two strains of... |
Pharmacol Biochem Be... |
1992 |
| Scheffel U, Lever JR, Sta... |
Repeated administration of MDMA causes transient down-regulation of se... |
Neuropharmacology |
1992 |
| Screaton GR, Singer M, Ca... |
Hyperpyrexia and rhabdomyolysis after MDMA ('ecstasy') abuse |
Lancet |
1992 |
| Gable RS |
Toward a Comparative Overview of Dependence Potential and Acute Toxici... |
Am J Drug Alcohol Ab... |
1993 |
| Emerson TS, Cisek JE |
Methcathinone: a Russian designer amphetamine infiltrates the rural mi... |
Ann Emerg Med |
1993 |
| Axt KJ, Mamounas LA, Moll... |
Structural Features of Amphetamine Neurotoxicity in the Brain. Ampheta... |
Academic Press San D... |
1994 |
| McGuire PK, Cope H, Fahy ... |
Diversity of psychopathology associated with use of 3,4-methylenedioxy... |
Br J Psychiatry |
1994 |
| Schifano F, Magni G |
MDMA ('ecstasy') abuse: psychopathological features and craving for ch... |
Biol Psychiatry |
1994 |
| Sarnyai Z, Kovacs GL |
Role of oxytocin in the neuroadaptation to drugs of abuse |
Psychoneuroendocrino... |
1994 |
| Ferrara SD, Tedeschi L, F... |
Fatality due to gamma-hydroxybutyric acid (GHB) and heroin intoxicatio... |
J Forensic Sci |
1995 |
| Dafters RI |
Hyperthermia following MDMA administration in rats: effects of ambient... |
Physiol Behav |
1995 |
| Abraham HD, Duffy FH |
Stable quantitative EEG difference in post-LSD visual disorder by spli... |
Psychiatry Res |
1996 |
| Fidler H, Dhillon A, Gert... |
Chronic ecstasy (3,4-methylenedioxymetamphetamine) abuse: a recurrent ... |
J Hepatol |
1996 |
| Kawasaki A, Purvin V |
Persistent palinopsia following ingestion of lysergic acid diethylamid... |
Arch Ophthalmol |
1996 |
| Bonson KR, Murphy DL |
Alterations in responses to LSD in humans associated with chronic admi... |
Behav Brain Res |
1996 |
